Slump In Generic Submissions Helps US FDA Draw Nearly Even With Approvals

 
• By Derrick Gingery
  
Generic drugs
The monthly approval rate would be the second-best of the GDUFA era if sustained through the second half of FY 2021. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics